Voloridge Investment Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $562,966 - $1.05 Million	56,353 New	56,353 $1.04 Million
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $1.3 Million - $2.26 Million	-104,114 Reduced 38.5%	166,327 $2.23 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $734,773 - $1.02 Million	-63,288 Reduced 18.96%	270,441 $3.35 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $259,499 - $418,684	21,253 Added 6.8%	333,729 $4.66 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $126,483 - $220,642	11,263 Added 3.74%	312,476 $4.32 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $871,951 - $1.16 Million	65,217 Added 27.63%	301,213 $4.9 Million
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $657,822 - $899,668	-46,066 Reduced 16.33%	235,996 $3.84 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $534,850 - $842,831	-41,174 Reduced 12.74%	282,062 $4.19 Million
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $578,961 - $917,500	-37,449 Reduced 10.38%	323,236 $6.46 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $205,651 - $401,622	-10,639 Reduced 2.87%	360,685 $8.33 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $1.38 Million - $2.4 Million	56,485 Added 17.94%	371,324 $9.17 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $11 Million - $15 Million	280,437 Added 815.18%	314,839 $13.1 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $370,331 - $729,877	7,930 Added 29.96%	34,402 $1.65 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $64,257 - $157,725	-1,329 Reduced 4.78%	26,472 $1.67 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.4 Million - $3.03 Million	24,411 Added 720.09%	27,801 $3.45 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $198,959 - $272,759	3,390 New	3,390 $225,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $433,489 - $672,670	-5,574 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $486,790 - $639,724	-5,301 Reduced 48.74%	5,574 $624,000
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $932,966 - $1.38 Million	10,875 New	10,875 $1.1 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $865,873 - $1.1 Million	-16,424 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $479,160 - $599,033	8,233 Added 100.51%	16,424 $959,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $466,968 - $972,681	8,191	8,191 $475,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account